View source for 20240041089. A NEW POWDER COMPOSITION simplified abstract (LIW INNOVATION AB)

=A NEW POWDER COMPOSITION=


==Organization Name==

[[:Category:LIW INNOVATION AB|LIW INNOVATION AB]]


[[Category:LIW INNOVATION AB]]

==Inventor(s)==

[[:Category:Johan Bj�rkholm of Ulricehamn (SE)|Johan Bj�rkholm of Ulricehamn (SE)]][[Category:Johan Bj�rkholm of Ulricehamn (SE)]]

[[:Category:Lars Bj�rkholm of Borås (SE)|Lars Bj�rkholm of Borås (SE)]][[Category:Lars Bj�rkholm of Borås (SE)]]

==A NEW POWDER COMPOSITION - A simplified explanation of the abstract==


This abstract first appeared for US patent application 20240041089 titled 'A NEW POWDER COMPOSITION

==Simplified Explanation==

The patent application discloses powder compositions with a pH of at least 6 for delivering an active agent to the nasal cavity. The active agent can be nicotine, tetrahydrocannabinol (THC), or ethanol. The compositions contain a filling agent of water-soluble and water-insoluble microcrystalline cellulose, a matrix forming agent, and have a defined brightness and particle size range. The application also includes products that incorporate these powder compositions and support particles to induce a desired property.

* The patent application describes powder compositions with a pH of at least 6 for nasal delivery of an active agent.
* The active agent can be nicotine, THC, or ethanol.
* The compositions contain water-soluble and water-insoluble microcrystalline cellulose as a filling agent.
* A matrix forming agent is also included in the compositions.
* The compositions have a defined brightness and particle size range.
* The patent application also covers products that incorporate these powder compositions and support particles to achieve a desired property.

Potential Applications:
* Nasal delivery of active agents such as nicotine, THC, or ethanol.
* Pharmaceutical industry for developing nasal drug delivery systems.
* Smoking cessation products.
* Medical cannabis products.

Problems Solved:
* Provides a pH-controlled powder composition for efficient delivery of active agents to the nasal cavity.
* Overcomes the limitations of traditional delivery methods for nicotine, THC, or ethanol.
* Enables precise control over the particle size and brightness of the compositions.

Benefits:
* Enhanced absorption and bioavailability of active agents through nasal delivery.
* Improved convenience and ease of use compared to other delivery methods.
* Customizable properties of the powder compositions for specific applications.
* Potential for targeted and localized drug delivery to the nasal cavity.


==Original Abstract Submitted==

disclosed are powder compositions with a ph of at least 6 for delivery of an active agent to the nasal cavity, wherein the active agent is selected from at least one of nicotine, tetrahydrocannabinol (thc) and ethanol. the compositions comprise a filling agent of water soluble and water insoluble microcrystalline cellulose and a matrix forming agent and have a defined brightness and particle size range. also disclosed are products including the powder compositions and support particles inducing a desired property to the product.



[[Category:A24B13/00]]
[[Category:A24B15/40]]
[[Category:A24B15/32]]
[[Category:A24B15/28]]